Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Thirdhand Smoke As a Risk Factor for Pediatric Lymphoblastic Leukemia: Accelerated Leukemia in Female Pax5 -P80R Mice

Mi Zhou, Antoine M Snijders, Jian-Hua Mao, Joseph L. Wiemels, Scott C Kogan

Blood (2024) 144 (Supplement 1): 5763.

https://doi.org/10.1182/blood-2024-206956

Published: 2024

Journal Articles

Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: A Report from the Children's Oncology Group

Elliot Stieglitz, Alex Lee, Steven P. Angus, Christopher Davis, Donald Barkauskas, David Hall, Scott C. Kogan, Julia Meyer, Steven D. Rhodes, Xiaoling Xuei, Kevin Shannon, Mignon L. Loh, Elizabeth Fox, Brenda J. Weigel

Blood (2023) 142 (Supplement 1): 74.

https://doi.org/10.1182/blood-2023-173153

Published: 2023

Journal Articles

PML-RARα: changing myeloid networks

Scott C. Kogan

Blood (2021) 137 (11): 1439–1440.

https://doi.org/10.1182/blood.2020008849

Published: 2021

Journal Articles

The Baf Subunit Dpf2 Regulates Resolution of Inflammation By Controlling Macrophage Differentiation Transcription Factor Networks

Gloria Mas Martin, PhD, Na Man, Daniel Karl, PhD, Concepcion Martinez, B.S., Stephanie Duffort, Hidehiro Itonaga, MD PhD, Adnan K Mookhtiar, BS, Daniel Bilbao, PhD, Kranthi Kunkalla, Alfredo M Valencia, Clayton Collings, Cigall Kadoch, PhD, Francisco Vega, MDPhD, Scott C. Kogan, MD, Stephen Nimer, MD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-142030

Published: 2020

Journal Articles

Genetic disruption of N-Ras G12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice

Noemi A. Zambetti, Ari J. Firestone, Jarrett R. Remsberg, Benjamin J. Huang, Jasmine C. Wong, Amanda M. Long, Marina Predovic, Radu M. Suciu, Anagha Inguva, Scott C. Kogan, Kevin M. Haigis, Benjamin F. Cravatt, Kevin Shannon

Blood (2020) 135 (20): 1772–1782.

https://doi.org/10.1182/blood.2019003530

Published: 2020

Includes: Supplemental data

Journal Articles

Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice

Edwige Voisset, Eva Moravcsik, Eva W. Stratford, Amie Jaye, Christopher J. Palgrave, Robert K. Hills, Paolo Salomoni, Scott C. Kogan, Ellen Solomon, David Grimwade

Blood (2018) 131 (6): 636–648.

https://doi.org/10.1182/blood-2017-07-794784

Published: 2018

Includes: Supplemental data

Journal Articles

Resistant T-Cell Acute Lymphoblastic Leukemias That Emerge after In Vivo Treatment with Dexamethasone Frequently Down-Regulate Glucocorticoid Receptor Protein Expression

Blood (2016) 128 (22): 753.

https://doi.org/10.1182/blood.V128.22.753.753

Published: 2016

Journal Articles

Identification of IRF8 As a Potent Tumor Suppressor in Murine Acute Promyelocytic Leukemia

Sangeetha Surianarayanan, Coline M Gaillard, Trevor Bentley, Matthew R. Warr, Briana Fitch, Huimin Geng, PhD, Emmanuelle Passegue, PhD, Hugues de Thé, MD PhD, Scott C. Kogan, MD

Blood (2016) 128 (22): 1518.

https://doi.org/10.1182/blood.V128.22.1518.1518

Published: 2016

Journal Articles

Genetic Subtypes of Human Pediatric ALLs Show Gene Expression Differences That Parallel Those Observed in Mouse B1 and B2 Progenitors, Suggesting Divergent Developmental Origins

Scott C. Kogan, Huimin Geng, PhD, Ritu Roy, Encarnacion Montecino-Rodriguez, Coline M Gaillard, Kamir Hiam, Henrik Bengtsson, David Casero, Adam B Olshen, Kenneth Dorshkind

Blood (2016) 128 (22): 1741.

https://doi.org/10.1182/blood.V128.22.1741.1741

Published: 2016

Journal Articles

Dilute Russell Viper Venom Time Interpretation and Clinical Correlation: A Two-Year Retrospective Institutional Review

Cyril Jacquot, MDPhD, Geoffrey D. Wool, MD PhD, Scott C. Kogan, MD

Blood (2016) 128 (22): 2609.

https://doi.org/10.1182/blood.V128.22.2609.2609

Published: 2016

Journal Articles

Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways

Edwige Voisset, PhD, Eva Moravcsik, Eva W Stratford, Amie Jaye, Christopher J Palgrave, Robert K Hills, DPhil, Paolo Salomoni, Scott C. Kogan, MD, Ellen Solomon, David Grimwade, PhD FRCPath

Blood (2016) 128 (22): 742.

https://doi.org/10.1182/blood.V128.22.742.742

Published: 2016

Journal Articles

Mechanism of IL-10 Protective Effect in Development of Childhood B Cell Acute Lymphoblastic Leukemia

Briana Fitch, Michelle L. Hermiston, MD PhD, Joseph L. Wiemels, PhD, Scott C. Kogan, MD

Blood (2016) 128 (22): 4075.

https://doi.org/10.1182/blood.V128.22.4075.4075

Published: 2016

Journal Articles

Preclinical efficacy of MEK inhibition in Nras -mutant AML

Michael R. Burgess, Eugene Hwang, Ari J. Firestone, Tannie Huang, Jin Xu, Johannes Zuber, Natacha Bohin, Tiffany Wen, Scott C. Kogan, Kevin M. Haigis, Deepak Sampath, Scott Lowe, Kevin Shannon, Qing Li

Blood (2014) 124 (26): 3947–3955.

https://doi.org/10.1182/blood-2014-05-574582

Published: 2014

Includes: Supplemental data

Journal Articles

Aberrant Hematopoietic Stem Cell Function in Mice Haploinsufficient for a 2 Mb Deletion of Chromosome 5A3 Syntenic to a Region of Human 7q22 Frequently Deleted in Myelodysplastic Syndromes

Jasmine C. Wong, PhD, Kelley Weinfurtner, BA, Pilar Alzamora, Scott C. Kogan, MD, Michael R. Burgess, MD PhD, Yan Zhang, PhD, Joy Nakitandwe, PhD, Jing Ma, PhD, Jinjun Cheng, MB, MS, Shann-Ching Chen, PhD, Johanna Flach, Damien Reynaud, PhD, Emmanuelle Passegue, PhD, James R Downing, MD, Kevin Shannon, MD

Blood (2014) 124 (21): 3247.

https://doi.org/10.1182/blood.V124.21.3247.3247

Published: 2014

Journal Articles

Preclinical Efficacy of MEK Inhibition in Nras Mutant Acute Myeloid Leukemia

Michael R. Burgess, MD PhD, Eugene Hwang, BA, Ari J Firestone, PhD, Tannie Huang, MD, Jin Xu, PhD, Johannes Zuber, MD, Natacha Bohin, BS, Tiffany Wen, BS, Scott C. Kogan, MD, Kevin M. Haigis, PhD, Scott W. Lowe, PhD, Kevin Shannon, MD, Qing Li, MD PhD

Blood (2014) 124 (21): 3753.

https://doi.org/10.1182/blood.V124.21.3753.3753

Published: 2014

Journal Articles

Disruption Of PML Nuclear Bodies Cooperates In The Pathogenesis Of Acute Promyelocytic Leukemia

Eva Moravcsik, Melanie Joannides, Edwige Voisset, Eva Wessel Stratford, Bernd B. Zeisig, Jo Morris, Ruth Densham, Chris Palgrave, Gordon Stamp, Emma Nye, Robert K. Hills, Paolo Salomoni, Chi Wai Eric So, PHD, Scott C. Kogan, Ellen Solomon, David Grimwade, MD, PhD

Blood (2013) 122 (21): 3721.

https://doi.org/10.1182/blood.V122.21.3721.3721

Published: 2013

Journal Articles

The Challenge Of Russell’s Viper Venom Time Interpretation For Lupus Anticoagulant Diagnosis: A Two-Year Retrospective Institutional Review

Geoffrey D. Wool, MD, PhD, Scott C. Kogan, MD

Blood (2013) 122 (21): 1131.

https://doi.org/10.1182/blood.V122.21.1131.1131

Published: 2013

Journal Articles

PML-RARα Deregulates an Unexpectedly Small Number of Genes in Pre-Leukemic Promyelocytes

Coline M Gaillard, Taku A Tokuyasu, PhD, Emmanuelle Passegué, PhD, Scott C. Kogan, MD

Blood (2012) 120 (21): 3526.

https://doi.org/10.1182/blood.V120.21.3526.3526

Published: 2012

Journal Articles

Evaluation of Patients with Bleeding Symptoms Using a Novel Perfusion Chamber Assay (PCA)

Matthew F. Gorman, MD, Scott C. Kogan, MD, James Huang, MD, Gillian Stephens, Ph.D.

Blood (2012) 120 (21): 3295.

https://doi.org/10.1182/blood.V120.21.3295.3295

Published: 2012

Journal Articles

Crenolanib (CP-868,596) Is a Potent and Selective Type I FLT3 Inhibitor That Retains Activity Against AC220 Resistance-Causing FLT3 Kinase Domain Mutants

Catherine C Smith, MD, Elisabeth Lasater, PhD, Melissa Mccreery, BS, Kimberly Lin, BS, Whitney Stewart, BS, Lauren E Damon, Alexander E Perl, MD, Grace R Jeschke, Mayumi Sugita, MD, Martin Carroll, MD, Scott C. Kogan, MD, Neil Shah, MD, PhD

Blood (2012) 120 (21): 141.

https://doi.org/10.1182/blood.V120.21.141.141

Published: 2012

NARROW

Thirdhand Smoke As a Risk Factor for Pediatric Lymphoblastic Leukemia: Accelerated Leukemia in Female Pax5 -P80R Mice

Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: A Report from the Children's Oncology Group

PML-RARα: changing myeloid networks

The Baf Subunit Dpf2 Regulates Resolution of Inflammation By Controlling Macrophage Differentiation Transcription Factor Networks

Genetic disruption of N-Ras G12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice

Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice

Resistant T-Cell Acute Lymphoblastic Leukemias That Emerge after In Vivo Treatment with Dexamethasone Frequently Down-Regulate Glucocorticoid Receptor Protein Expression

Identification of IRF8 As a Potent Tumor Suppressor in Murine Acute Promyelocytic Leukemia

Genetic Subtypes of Human Pediatric ALLs Show Gene Expression Differences That Parallel Those Observed in Mouse B1 and B2 Progenitors, Suggesting Divergent Developmental Origins

Dilute Russell Viper Venom Time Interpretation and Clinical Correlation: A Two-Year Retrospective Institutional Review

Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways

Mechanism of IL-10 Protective Effect in Development of Childhood B Cell Acute Lymphoblastic Leukemia

Preclinical efficacy of MEK inhibition in Nras -mutant AML

Aberrant Hematopoietic Stem Cell Function in Mice Haploinsufficient for a 2 Mb Deletion of Chromosome 5A3 Syntenic to a Region of Human 7q22 Frequently Deleted in Myelodysplastic Syndromes

Preclinical Efficacy of MEK Inhibition in Nras Mutant Acute Myeloid Leukemia

Disruption Of PML Nuclear Bodies Cooperates In The Pathogenesis Of Acute Promyelocytic Leukemia

The Challenge Of Russell’s Viper Venom Time Interpretation For Lupus Anticoagulant Diagnosis: A Two-Year Retrospective Institutional Review

PML-RARα Deregulates an Unexpectedly Small Number of Genes in Pre-Leukemic Promyelocytes

Evaluation of Patients with Bleeding Symptoms Using a Novel Perfusion Chamber Assay (PCA)

Crenolanib (CP-868,596) Is a Potent and Selective Type I FLT3 Inhibitor That Retains Activity Against AC220 Resistance-Causing FLT3 Kinase Domain Mutants

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only